ATE65694T1 - Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum. - Google Patents

Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum.

Info

Publication number
ATE65694T1
ATE65694T1 AT85308748T AT85308748T ATE65694T1 AT E65694 T1 ATE65694 T1 AT E65694T1 AT 85308748 T AT85308748 T AT 85308748T AT 85308748 T AT85308748 T AT 85308748T AT E65694 T1 ATE65694 T1 AT E65694T1
Authority
AT
Austria
Prior art keywords
sedative
analgesic
medication
usable
manufacture
Prior art date
Application number
AT85308748T
Other languages
German (de)
English (en)
Inventor
Raimo Einari Virtanen
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Antti Tapani Vaha-Vahe
Outi Maritta Vainio-Kivinen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE65694T1 publication Critical patent/ATE65694T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Stringed Musical Instruments (AREA)
AT85308748T 1984-12-04 1985-12-02 Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum. ATE65694T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.
EP85308748A EP0187471B1 (en) 1984-12-04 1985-12-02 Use of a substituted imidazole for the manufacture of a medicament useful as a sedative or analgesic

Publications (1)

Publication Number Publication Date
ATE65694T1 true ATE65694T1 (de) 1991-08-15

Family

ID=8520010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85308748T ATE65694T1 (de) 1984-12-04 1985-12-02 Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum.

Country Status (11)

Country Link
US (1) US4670455A (enExample)
EP (1) EP0187471B1 (enExample)
JP (1) JPS61134314A (enExample)
AT (1) ATE65694T1 (enExample)
AU (1) AU572364B2 (enExample)
DE (1) DE3583670D1 (enExample)
DK (1) DK163960C (enExample)
FI (1) FI844786A0 (enExample)
IE (1) IE58269B1 (enExample)
NZ (1) NZ213604A (enExample)
ZA (1) ZA858416B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
BR112016006848A2 (pt) 2013-10-07 2017-08-01 Teikoku Pharma Usa Inc métodos e composições para distribuição transdérmica de uma quantidade não sedativa de dexmedetomidina
ES2856189T3 (es) 2013-10-07 2021-09-27 Teikoku Pharma Usa Inc Métodos y composiciones para el tratamiento del trastorno de hiperactividad por déficit de atención, ansiedad e insomnio utilizando composiciones transdérmicas de dexmedetomidina
CN110585173A (zh) 2013-10-07 2019-12-20 帝国制药美国公司 右旋美托咪啶经皮递送装置及其使用方法
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
US12527770B2 (en) 2016-10-31 2026-01-20 Teikoku Pharma Usa, Inc. Methods of managing pain using dexmedetomidine transdermal delivery devices
AU2017388759B2 (en) 2016-12-31 2021-11-11 Bioxcel Therapeutics, Inc. Use of sublingual Dexmedetomidine for the treatment of agitation
ES3004544T3 (en) 2018-06-27 2025-03-12 Bioxcel Therapeutics Inc Film formulations containing dexmedetomidine and methods of producing them
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
US20240024288A1 (en) 2019-07-19 2024-01-25 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
AU566014B2 (en) * 1982-08-14 1987-10-08 Wellcome Foundation Limited, The Imidazole derivatives

Also Published As

Publication number Publication date
DE3583670D1 (de) 1991-09-05
FI844786A0 (fi) 1984-12-04
JPS61134314A (ja) 1986-06-21
AU572364B2 (en) 1988-05-05
US4670455A (en) 1987-06-02
EP0187471A3 (en) 1988-09-14
IE853024L (en) 1986-06-04
DK508985A (da) 1986-06-05
JPH0465050B2 (enExample) 1992-10-16
DK163960C (da) 1992-09-21
DK163960B (da) 1992-04-27
IE58269B1 (en) 1993-08-25
EP0187471A2 (en) 1986-07-16
DK508985D0 (da) 1985-11-05
ZA858416B (en) 1986-07-30
EP0187471B1 (en) 1991-07-31
NZ213604A (en) 1988-09-29
AU4997185A (en) 1986-06-12

Similar Documents

Publication Publication Date Title
ATE65694T1 (de) Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum.
ES2045229T3 (es) Pirrolidinas 1,3-disubstituidas.
YU47204B (sh) Derivati didehidro-vitamina d3
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
GB2215206B (en) 4-substituted imidazole derivatives useful in perioperative care
YU47809B (sr) Novi ergolin-8-karboksamidi i postupak za njihovo dobijanje
NO911233L (no) Nye retinoider.
ES8403463A1 (es) "un procedimiento para la preparacion de un compuesto de imidazol".
KR840006230A (ko) 1-페닐-2-메틸-3-(1-피로리디닐)-1-프로판온 유도체의 제조방법
KR880005120A (ko) 불안해소제 및 우울증 치료제로서의 가교된 비사이클릭 이미드
ES2125574T3 (es) Procedimiento para la preparacion de (-)-n-metil-n-(4-(4-fenil-4-acetilaminopiperidin-1-il)-2-(3,4-diclorofenil)butil)-benzamida y sus sales farmaceuticamente aceptables.
FI880987A0 (fi) 1-(1-aryl-2-hydroxietyl) imidazoler och deras salter, foerfarande foer deras framstaellning, laekemedel innehaollande dessa foereningar och deras anvaendning.
IT1190818B (it) Procedimento per la produzione di alfa-aminoderivati ciclici di 1-(3',4'-metilendiossifenil)etanolo
MX9300763A (es) Imidazoles sustituidos por sulfonilbencilo, procedimiento para su obtencion, medicamentos que los contienen y procedimiento para la obtencion de tales medicamentos
ES499422A0 (es) Procedimiento para preparar benzofurilpiperazinas
ES2039273T3 (es) Compuestos antimicoticos a base de combinaciones de nicomicina y azol antimicotico.
ATE71835T1 (de) Verwendung von 2-((2-brom-6fluorphenyl)imino>imidazolidin als sedativum.
SE8503443L (sv) Ny azol, forfarande for dess framstellning och anvendning derav
ES2078976T3 (es) Dosificador que comprende un tonoforo.
FI822552L (fi) Insektlockaemne
ES535341A0 (es) Procedimiento para la obtencion de 1-(2,4-diclorofenil)-2-(1h-imidazol-1-il)-1-(2,4-diclorobenciloximino)
SU820186A1 (ru) 1-[4-(3',4'-диоксифенил)-тиазолил-2]-3-алкил-5-тетрафторэтилпиразолы, обладающие акарицидной активностью
ECSP961643A (es) '2-(2-n-alcoxifenil-)-purin-6 onas- 9 sustituidas lea 30701- ec
IT1111152B (it) Processo per la preparazione dell'1-(2,4iclorofenil)-1-(4-clorofenil)metosso)-2-(imidazolil-1-etano

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time